Connect with us
.png){kind=small}
Schedule a Consultation!
Blog
Does Vitamin D Raise Testosterone? What the Randomized Trials Actually Show
Randomized trials do not show that vitamin D raises testosterone. What the 2026 meta-analysis found, why the famous 2011 study is weaker than it looks, and what to do instead if you have low-T symptoms.
Am I a Candidate for TRT? Who Qualifies for Testosterone Therapy
A physician-reviewed guide to TRT candidacy: the two findings required for a diagnosis, why 300 ng/dL is not an automatic threshold, what delays or rules out treatment, and the conditions commonly mistaken for low testosterone.
Tesamorelin for Women: What the Evidence and FDA Label Actually Say
Can women use tesamorelin? A physician-reviewed look at what the FDA label and clinical trials actually say about abdominal fat, dosing, pregnancy, side effects and monitoring.
NovaGenix Celebrates 10 Years: A Decade of Care, Community and Connection
From a friendship formed through Brazilian jiu-jitsu to a physician-led practice in Jupiter, NovaGenix celebrates ten years of care, community and patient relationships.
Enclomiphene vs. TRT: Benefits, Fertility, Risks, and Cost
Compare two approaches to low testosterone, with a focus on fertility goals, symptom evidence, side effects, testing, and the complete cost of care.
Kickoff Warning: Peptides, Steroids, and Why a College Football Season Can End Before Week 1
A physician-led guide to NCAA banned peptides, steroids, medical exceptions, supplement risk, and what athletes should verify before taking anything.
Perimenopause vs. Menopause: What's the Difference?
Perimenopause is a years-long transition; menopause is confirmed after 12 months without a period. Learn how symptoms, diagnosis, and treatment differ.
What the July 2026 FDA Peptide Vote Actually Means for Patients
An FDA advisory committee recommended six peptide substances for possible 503A-list inclusion in July 2026. Here is what that nonbinding vote means—and what it does not mean—for patients.
Retatrutide: What It Is, What the Research Shows, and When You Can Get It
Retatrutide is an investigational triple agonist—not an FDA-approved medication. Learn what Phase 2 and Phase 3 research shows, known risks, and what patients can legally access today.
Schedule a Consultation
Learn what you want to know about hormone therapy by scheduling a free consultation.
Contact Us Today
609 N Hepburn Ave Ste 106, Jupiter, FL 33458
Monday - Friday: 9:00 am - 5:00 pm | Saturday-Sunday: Closed
